I am sure everyone has seen remdesivir got approved for Covid treatment for some severe cases. Could greatly impact CYDY's leronlimab at least short term.

A lesson to be learned. A small biotech can't do a clinical trial operating on a shoe string budget and expect big pharma to not beat you to the finish line. You had better have great researchers with extensive patient trial populations to choose from.